Luca Benatti's most recent trade in Quince Therapeutics Inc was a trade of 50,000 Common Stock done at an average price of $3.5 . Disclosure was reported to the exchange on Dec. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Luca Benatti | Director | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 26 Dec 2025 | 50,000 | 39,179 (0%) | 0% | 3.5 | 173,500 | Common Stock |
| Quince Therapeutics Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 27,000 | 27,000 | - | - | Director Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Luca Benatti | Director | Other type of transaction at price $ 0.00 per share. | 23 Oct 2024 | 8,918 | 89,179 (0%) | 0% | - | Common Stock | |
| Quince Therapeutics Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 27,000 | 27,000 | - | - | Employee Stock Option (right to buy) | |
| Intercept Pharmaceuticals Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 12,547 | 12,547 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 8,111 | 33,598 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 12,790 | 12,790 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 7,737 | 25,487 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 12,089 | 12,089 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Luca Benatti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,029 | 17,750 (0%) | 0% | 0 | Common Stock |